MARKET

CANF

CANF

Can-Fite BioPharma Ltd.
AMEX
4.650
+0.210
+4.73%
After Hours: 4.650 0 0.00% 18:31 02/20 EST
OPEN
4.450
PREV CLOSE
4.440
HIGH
4.650
LOW
4.290
VOLUME
31.26K
TURNOVER
--
52 WEEK HIGH
46.60
52 WEEK LOW
3.356
MARKET CAP
6.09M
P/E (TTM)
-0.0036
1D
5D
1M
3M
1Y
5Y
1D
Can-Fite Targets Rare Kidney Disease With New Phase 2 Lowe Syndrome Trial
TipRanks · 4d ago
Can-Fite Showcases Namodenoson Anti-Obesity Data in Peer-Reviewed Journal
TipRanks · 5d ago
Can-Fite BioPharma Announces Publication Of Peer-Reviewed Study In International Journal Of Obesity Demonstrating Anti-Obesity Effect Of Namodenoson
Benzinga · 5d ago
Can-Fite BioPharma Reports Namodenoson Reduces Weight Gain in Obesity Study
Reuters · 5d ago
Weekly Report: what happened at CANF last week (0209-0213)?
Weekly Report · 6d ago
Can-Fite BioPharma Wins Canadian Patent Allowance for Namodenoson Obesity Use
TipRanks · 02/09 12:27
Can-Fite BioPharma receives Canadian patent allowance for namodenoson
TipRanks · 02/09 12:15
Can-Fite BioPharma Secures Canadian Patent Allowance For A3 Adenosine Receptor Ligand Targeting Fat Loss
Benzinga · 02/09 12:07
More
About CANF
Can Fite Biopharma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. Its technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.

Webull offers Can Fite Biopharma Ltd stock information, including AMEX: CANF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CANF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CANF stock methods without spending real money on the virtual paper trading platform.